Randomized EMS trial found no significant dispatcher recognition gain from machine-learning alerts

Dispatch leaders and medical directors need to reduce missed emergencies while managing interruptions and finite response capacity. Ask about local recognition baselines, false-alert tolerance, call mix and who reviews adverse events. A credible value hypothesis is that a carefully tuned copilot may improve a specific workflow if tested prospectively. Offer an evaluation-design and readiness engagement that includes clinical quality assurance, frontline staff and IT. Do not quote superior standalone sensitivity as demonstrated human-team improvement or promise lives saved. The Danish setting limits transferability, and current products require their own evidence. Commercial discovery should establish whether the agency can support a controlled pilot and independent review before proposing broad deployment.

Integrate a read-only audio branch and advisory display behind existing call handling, retaining an immediate return to normal protocols. Establish consent or other lawful processing, secure outcome linkage and an independently adjudicated reference set before testing. Validate peak concurrency, alert delays, outage recovery and model-version traceability. Use shadow operation to estimate false positives and false negatives, followed by an approved prospective comparison of team performance. Distinguish missed model events from ignored alerts and pipeline failures. Proposed validation includes no delay to the primary call path, measured availability and clinical endpoints agreed by the medical director. Security tests should cover audio exposure, account scope, retention and logs.

Name a clinical quality lead, dispatch supervisor and service-reliability owner. Map current recognition and escalation workflows, prepare training, run shadow evaluation and review results before exposing alerts during an authorized pilot. Secure data-sharing dependencies and sufficient reviewer capacity. Governance checkpoints should cover baseline quality, threshold selection, any adverse event and each material model change. Proposed acceptance requires prespecified clinical performance criteria, documented false-alert workload, tested fallback and monitoring of staff adoption without penalizing justified overrides. No threshold here is an observed local result. Risks include alert fatigue, automation bias, selective outcome measurement and outage-induced blind spots; maintain a stop rule and a documented rollback procedure.